Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Thromb Res ; 130(2): 248-52, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22094133

RESUMEN

INTRODUCTION: During exercise, ischemic risk increases, possibly due to changes in coagulation and fibrinolytic activity. Previous research suggests ambient temperature affects resting thrombotic potential, but the effect of heat and cold on hemostasis during exercise is unknown. The purpose of this study was to assess changes in coagulation and fibrinolysis during maximal exercise in hot and cold temperatures, and to compare those responses to exercise under temperate conditions. MATERIALS & METHODS: Fifteen healthy men completed maximal exercise tests in hot (30°C), temperate (20°C) and cold (5° - 8°C) temperatures. Blood samples were obtained before and immediately after exercise and analyzed for concentrations of thrombin-antithrombin III (TAT), active tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1). Results were analyzed by ANOVA. RESULTS: A main effect of time was observed for TAT (temperate=1.71 ± 0.82 - 2.61 ± 0.43 ng/ml, hot=1.81 ± 0.73 - 2.62 ± 0.67 ng/ml, cold=2.33 ± 0.65 - 2.89 ± 0.81 ng/ml, PRE to POST, respectively) and tPA activity (temperate=0.72 ± 0.44 - 2.71 ± 0.55 IU/ml, hot=0.72 ± 0.38 - 2.64 ± 0.61 IU/ml, cold=0.86 ± 0.45 - 2.65 ± 0.77 IU/ml, PRE to POST, respectively). A trend was observed for the PAI-1 response to exercise (temperate=14.5 ± 23.7 - 12.3 ± 20.2I U/ml, hot=15.1 ± 26.5 - 10.0 ± 15.1 IU/ml, cold=10.5 ± 10.4 - 7.9 ± 9.7 IU/ml, PRE to POST, respectively, p=0.08). TAT concentrations were significantly higher in cold compared to temperate and hot conditions. CONCLUSION: Coagulation potential is elevated during exposure to cold temperatures. These data suggest that risk of an ischemic event may be elevated in the cold.


Asunto(s)
Coagulación Sanguínea , Ejercicio Físico , Fibrinólisis , Trombosis/sangre , Adulto , Análisis de Varianza , Antitrombina III , Frío , Prueba de Esfuerzo , Calor , Humanos , Masculino , Péptido Hidrolasas/sangre , Inhibidor 1 de Activador Plasminogénico/sangre , Factores de Riesgo , Trombosis/etiología , Activador de Tejido Plasminógeno/sangre , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA